Erin Wright
Stock Analyst at Morgan Stanley
(4.53)
# 274
Out of 4,712 analysts
206
Total ratings
64.47%
Success rate
14.16%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PDCO Patterson Companies | Maintains: Equal-Weight | $27 → $31 | $30.90 | +1.46% | 7 | Dec 17, 2024 | |
| MCK McKesson | Maintains: Overweight | $612 → $642 | $579.13 | +10.86% | 5 | Dec 17, 2024 | |
| PAHC Phibro Animal Health | Maintains: Equal-Weight | $20 → $25 | $21.64 | +15.53% | 21 | Dec 17, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Overweight | $30 → $23 | $18.90 | +21.69% | 12 | Dec 17, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $19 → $20 | $17.44 | +14.68% | 2 | Dec 17, 2024 | |
| HUM Humana | Maintains: Equal-Weight | $288 → $301 | $255.52 | +17.80% | 2 | Dec 17, 2024 | |
| CAH Cardinal Health | Maintains: Overweight | $127 → $136 | $118.83 | +14.45% | 8 | Dec 17, 2024 | |
| DGX Quest Diagnostics | Upgrades: Overweight | $145 → $172 | $153.42 | +12.11% | 5 | Dec 17, 2024 | |
| ALGN Align Technology | Maintains: Overweight | $310 → $280 | $213.50 | +31.15% | 20 | Oct 24, 2024 | |
| ELV Elevance Health | Maintains: Overweight | $643 → $551 | $372.94 | +47.74% | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $9 → $7 | $9.19 | -23.83% | 7 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $17 → $15 | $11.88 | +26.26% | 9 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6.5 → $3.5 | $5.07 | -30.97% | 11 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $620 → $596 | $413.62 | +44.09% | 11 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $33 → $21 | $18.95 | +10.82% | 6 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $382 → $392 | $280.06 | +39.97% | 3 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $69 → $65 | $70.01 | -7.16% | 4 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $44.25 | +125.99% | 4 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $506.10 | +15.98% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $264 → $248 | $164.71 | +50.57% | 5 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $229.49 | +30.72% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $21.36 | +96.63% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $230.75 | +24.81% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $186.29 | +88.95% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $5.33 | +725.52% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $342.69 | -47.18% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $91.30 | -81.38% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $35.01 | +245.62% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $528.98 | +9.64% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $10.70 | +227.10% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $213.26 | -3.87% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $18.51 | -40.57% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $199.99 | -21.50% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $38 | $21.51 | +76.66% | 1 | May 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $12.72 | +33.65% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $488.13 | -36.90% | 1 | Oct 25, 2017 |
Patterson Companies
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $27 → $31
Current: $30.90
Upside: +1.46%
McKesson
Dec 17, 2024
Maintains: Overweight
Price Target: $612 → $642
Current: $579.13
Upside: +10.86%
Phibro Animal Health
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20 → $25
Current: $21.64
Upside: +15.53%
DENTSPLY SIRONA
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $18.90
Upside: +21.69%
BrightSpring Health Services
Dec 17, 2024
Maintains: Overweight
Price Target: $19 → $20
Current: $17.44
Upside: +14.68%
Humana
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $288 → $301
Current: $255.52
Upside: +17.80%
Cardinal Health
Dec 17, 2024
Maintains: Overweight
Price Target: $127 → $136
Current: $118.83
Upside: +14.45%
Quest Diagnostics
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $153.42
Upside: +12.11%
Align Technology
Oct 24, 2024
Maintains: Overweight
Price Target: $310 → $280
Current: $213.50
Upside: +31.15%
Elevance Health
Oct 23, 2024
Maintains: Overweight
Price Target: $643 → $551
Current: $372.94
Upside: +47.74%
Oct 11, 2024
Maintains: Underweight
Price Target: $9 → $7
Current: $9.19
Upside: -23.83%
Sep 19, 2024
Downgrades: Equal-Weight
Price Target: $17 → $15
Current: $11.88
Upside: +26.26%
Jun 12, 2024
Maintains: Underweight
Price Target: $6.5 → $3.5
Current: $5.07
Upside: -30.97%
May 14, 2024
Maintains: Overweight
Price Target: $620 → $596
Current: $413.62
Upside: +44.09%
Apr 26, 2024
Downgrades: Equal-Weight
Price Target: $33 → $21
Current: $18.95
Upside: +10.82%
Mar 4, 2024
Reiterates: Overweight
Price Target: $382 → $392
Current: $280.06
Upside: +39.97%
Nov 14, 2023
Maintains: Underweight
Price Target: $69 → $65
Current: $70.01
Upside: -7.16%
Nov 2, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $44.25
Upside: +125.99%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $506.10
Upside: +15.98%
Nov 15, 2022
Maintains: Overweight
Price Target: $264 → $248
Current: $164.71
Upside: +50.57%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $229.49
Upside: +30.72%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $21.36
Upside: +96.63%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $230.75
Upside: +24.81%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $186.29
Upside: +88.95%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $5.33
Upside: +725.52%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $342.69
Upside: -47.18%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $91.30
Upside: -81.38%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $35.01
Upside: +245.62%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $528.98
Upside: +9.64%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $10.70
Upside: +227.10%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $213.26
Upside: -3.87%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $18.51
Upside: -40.57%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $199.99
Upside: -21.50%
May 9, 2018
Maintains: Outperform
Price Target: $42 → $38
Current: $21.51
Upside: +76.66%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $12.72
Upside: +33.65%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $488.13
Upside: -36.90%